Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study

Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study

Abstract Background IGF-1 is an essential neurotrophin produced peripherally and in the brain. Impairments in the brain IGF-1 concentrations might be responsible for some aspects of major depressive disorder (MDD) pathogenesis, whereas peripheral IGF-1 could have the marker value. We aimed: 1) to co...

Full description

Bibliographic Details
Main Authors: Oleg A. Levada, Alexandra S. Troyan, Irina Y. Pinchuk
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Psychiatry
Subjects:
IGF-1
Depression
Cognitions
Vortioxetine
Online Access:http://link.springer.com/article/10.1186/s12888-020-02636-7

Internet

http://link.springer.com/article/10.1186/s12888-020-02636-7

Similar Items